Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings

The market for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s (SHSE:603392) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem.

Check out our latest analysis for Beijing Wantai Biological Pharmacy Enterprise

The Impact Of Unusual Items On Profit

For anyone who wants to understand Beijing Wantai Biological Pharmacy Enterprise's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥162m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Beijing Wantai Biological Pharmacy Enterprise to produce a higher profit next year, all else being equal.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Beijing Wantai Biological Pharmacy Enterprise's Profit Performance

Unusual items (expenses) detracted from Beijing Wantai Biological Pharmacy Enterprise's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Beijing Wantai Biological Pharmacy Enterprise's statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about Beijing Wantai Biological Pharmacy Enterprise as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 1 warning sign for Beijing Wantai Biological Pharmacy Enterprise you should know about.

This note has only looked at a single factor that sheds light on the nature of Beijing Wantai Biological Pharmacy Enterprise's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.